Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate‐Gene Studies
Authors:
- 31 December 2012
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 37 (2) , 222-228
Abstract
Genomewide association studies (GWAS) and candidate‐gene studies have implicated single‐nucleotide polymorphisms (SNPs) in at least 45 different genes as putative glioma risk factors. Attempts to validate these associations have yielded variable results and few genetic risk factors have been consistently replicated. We conducted a case‐control study of Caucasian glioma cases and controls from the University of California San Francisco (810 cases, 512 controls) and the Mayo Clinic (852 cases, 789 controls) in an attempt to replicate previously reported genetic risk factors for glioma. Sixty SNPs selected from the literature (eight from GWAS and 52 from candidate‐gene studies) were successfully genotyped on an Illumina custom genotyping panel. Eight SNPs in/near seven different genes (TERT, EGFR, CCDC26, CDKN2A, PHLDB1, RTEL1, TP53) were significantly associated with glioma risk in the combined dataset (P < 0.05), with all associations in the same direction as in previous reports. Several SNP associations showed considerable differences across histologic subtype. All eight successfully replicated associations were first identified by GWAS, although none of the putative risk SNPs from candidate‐gene studies was associated in the full case‐control sample (all P values > 0.05). Although several confirmed associations are located near genes long known to be involved in gliomagenesis (e.g., EGFR, CDKN2A, TP53), these associations were first discovered by the GWAS approach and are in noncoding regions. These results highlight that the deficiencies of the candidate‐gene approach lay in selecting both appropriate genes and relevant SNPs within these genes.Keywords
This publication has 39 references indexed in Scilit:
- Chromosome 7p11.2 (EGFR) variation influences glioma riskHuman Molecular Genetics, 2011
- DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in GliomaJNCI: Journal of the National Cancer Institute, 2011
- Single nucleotide polymorphisms in IL-4Ra IL-13 and STAT6 genes occurs in brain gliomaFrontiers in Bioscience-Elite, 2011
- Distinct germ line polymorphisms underlie glioma morphologic heterogeneityCancer Genetics, 2011
- Inherited variation in immune genes and pathways and glioblastoma riskCarcinogenesis, 2010
- Allergy and glioma risk: Test of association by genotypeInternational Journal of Cancer, 2010
- Association between EGF +61 G/A and glioma risk in a Chinese populationBMC Cancer, 2010
- A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese populationJournal of Cancer Research and Clinical Oncology, 2010
- Genome-wide association study identifies five susceptibility loci for gliomaNature Genetics, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009